| Drug Name | Mayzent (Siponimod) |
|---|---|
| Drug Class |
Anti-inflammation
|
| Risk minimization type |
Patient Card
patient guide
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
Dosing and potential risks, including bradyarrhythmia, Immunosuppressive effect, liver injury and risk to the fetus. |
| Patient card |
|
| patient guide |
|
| Healthcare provider checklist |
|
| other |
|